Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;89(6):1719-1723.
doi: 10.1111/bcp.15717. Epub 2023 Apr 4.

Intravenous Lipid Emulsion does NOT have a role in severe poisoning: CON

Affiliations
Free article

Intravenous Lipid Emulsion does NOT have a role in severe poisoning: CON

Andis Graudins et al. Br J Clin Pharmacol. 2023 Jun.
Free article

Abstract

Intravenous lipid emulsion (ILE) has been suggested as a potential universal antidote for cardiovascular and central nervous system toxicity resulting from a multitude of pharmaceutical and nonpharmaceutical poisonings. While there is some evidence to suggest that ILE may have a positive effect in cardiovascular system toxicity after accidental intravenous lipophilic local anaesthetic overdose, this cannot be extrapolated to cases of severe poisoning resulting from oral drug overdose. Treatment recommendations are based upon variable outcome animal studies and low-level clinical evidence with a significant degree of positive reporting bias. Currently, there is a paucity of controlled clinical data to support ILE use to treat severe drug poisoning after oral overdose. ILE use should be limited to well-designed, ethically approved, controlled clinical trials aimed at determining the true effectiveness of this therapy. This should replace the current scattergun clinical use in a multiplicity of poisoning scenarios and subsequent anecdotal reporting approach.

Keywords: cardiac arrest; cardiovascular; extracorporeal membrane oxygenation; intravenous lipid emulsion; local anaesthetics; overdose; poisoning.

PubMed Disclaimer

References

REFERENCES

    1. Weinberg G, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88(4):1071-1075. doi:10.1097/00000542-199804000-00028
    1. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006;105(1):217-218. doi:10.1097/00000542-200607000-00033
    1. Fettiplace MR, Weinberg G. The mechanisms underlying lipid resuscitation therapy. Reg Anesth Pain Med. 2018;43(2):138-149. doi:10.1097/AAP.0000000000000719
    1. Rothschild L, Bern S, Oswald S, Weinberg G. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med. 2010;18(51):1-8. doi:10.1186/1757-7241-18-51
    1. American College of Medical T. ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7(1):81-82. doi:10.1007/s13181-010-0125-3

MeSH terms

LinkOut - more resources